Pupillary effects of levodopa therapy. Development of anisocoria in latent Horner's syndrome.
D003042:Cocaine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D004106:Dilatation; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005123:Eye / Q000294:innervation; D005128:Eye Diseases / Q000139:chemically induced / Q000150:complications; D006732:Horner Syndrome / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy; D011128:Polyradiculopathy / Q000150:complications; D011680:Pupil / Q000187:drug effects*; D013564:Sympathetic Nervous System / Q000187:drug effects
D004295:Dihydroxyphenylalanine; D003042:Cocaine; D004298:Dopamine; D004837:Epinephrine